<?xml version="1.0" encoding="iso-8859-1"?>
	<!-- 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
		XML Comment inserted to enable XSL in Firefox 2.0 
	-->
	<?xml-stylesheet type="text/xsl" href="http://www.phgfoundation.org/public/templates/foundation_corp/xsl/newsletter.xsl"?>
	<rss version="2.0">
		<channel>
		<title>Articles from the PHG Foundation Newsletter</title>
		<link>http://www.phgfoundation.org/newsletter</link>
		<description>Articles from the PHG Foundation Newsletter</description>
		<copyright>PHG Foundation</copyright>
		<list_type>news</list_type>
		<customJS>http://www.phgfoundation.org/rss/newsletter.xml?format=js</customJS>
		
				<item>
			<title>Genomic-based diagnostics show their potential</title>
			<link>http://www.phgfoundation.org/news/month/04/2008/#story_4049</link>
			<pubDate>Wed, 02 Apr 2008 00:00:00 +0100</pubDate>
			<description><![CDATA[ An increasing number of studies are taking place with the aim of identifying the genetic basis of common conditions that have a have a major public health impact such as cardiovascular disease, various cancers and obesity. Such studies are expected to increase understanding of disease processes and  ... ]]></description>
		</item>
				<item>
			<title>New pharmacogenetics research consortium</title>
			<link>http://www.phgfoundation.org/news/month/10/2007/#story_3783</link>
			<pubDate>Tue, 02 Oct 2007 00:00:00 +0100</pubDate>
			<description><![CDATA[ Seven major pharmaceutical companies have joined with academic centres, the US Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products (EMEA)&amp;nbsp; to form a new group, the International Serious Adverse Events Consortium (SAEC). The SAEC will work together ... ]]></description>
		</item>
			</channel>
</rss>